Back to article: The copper transport-associated protein Ctr4 can form prion-like epigenetic determinants in Schizosaccharomyces pombe


FIGURE 1: Fission yeast can support formation and propagation of the budding yeast [PSI+] prion.

(A) Left: Fluorescent foci in S. pombe resulting from overexpression of S. cerevisiae Sup35-GFP, using the medium-strength, regulatable nmt41 promoter under activating conditions from a high-copy plasmid. This result resembles the patterns seen when ScSup35-GFP is overexpressed from a high-copy plasmid in S. cerevisiae [47]. Middle: The foci are absent from cells grown for 35-40 generations in 3 mM guanidine hydrochloride (GndHCl). Right: Most GFP-tagged S. pombe proteins do not show fluorescent foci when overexpressed (see also [54]); the uncharacterized protein SPCC825.01(predicted ATPase) serves as an example for such a negative control, showing diffuse cytoplasmic localization.

(B) Transformation of S. pombe cell extract containing ScSup35-GFP aggregates can convert S. cerevisiae [psi] cells (red, streak 1) to [PSI+] cells (white, streaks 2-4 and 6-8). Streaks 1 and 5 show control [psi] and [PSI+] strains, respectively.

47. Zhou P, Derkatch IL, Liebman SW (2001). The relationship between visible intracellular aggregates that appear after overexpression of Sup35 and the yeast prion-like elements [PSI(+)] and [PIN(+)]. Mol Microbiol 39(1): 37-46. http://www.ncbi.nlm.nih.gov/pubmed/?term=11123686

54. Matsuyama A, Arai R, Yashiroda Y, Shirai A, Kamata A, Sekido S, Kobayashi Y, Hashimoto A, Hamamoto M, Hiraoka Y, Horinouchi S, Yoshida M (2006). ORFeome cloning and global analysis of protein localization in the fission yeast Schizosaccharomyces pombe. Nat Biotechnol 24(7): 841-847. https://doi.org/10.1038/nbt1222

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this. Please refer to our "privacy statement" and our "terms of use" for further information.

Close